Intra-Cellular Therapies (“ITCI”) Stock Soars While Key Clinical Data Not Presented to Shareholders Looks Highly Disappointing

(July 15th, 2015) Biotech stocks have been on fire. And for good reason as numerous life-saving discoveries have come out of small, previously-unknown firms, making their owners rich many times over. But beneath the surface, a number of troubling drug development companies have caught the attention of investors with clinical data that’s dubious at best. With seemingly endless amounts of optimism, these biotech stocks have ridden the wave of investor enthusiam even when the data doesn’t look as promising as the market caps seem to indicate.

Read more

All You Ever Wanted to Know About Retrophin But Were Afraid to Ask

(June 2nd, 2014) Humans, like atoms, abhor unsteady states of existence. Just like electron transport gravitates towards a steady-state, people gravitate towards peaceful lands and away from battleground areas. Read more

Know What to Buy When Putin Comes Knocking

So Putin rolls a bunch of tanks up to the Ukrainian border and the market slides a percent or so. In any other market that would be considered a yawn. But here in the good ‘ol US of A, where the average active investor can barely remember the dog days of ’08, few traders seem to have the skill set necessary to maneuver in a down market. Having done this for 20+ years, I thought it would be helpful to share my trading tips for when war comes knocking.
Read more

Little Bear Investments LLC Participates in GoAmerica, Inc. $14.5 Million Private Placement

Wednesday November 26, 2003, 12:45 pm ET

NEW YORK, November 17 — Little Bear Investments LLC (“Little Bear”) announced today that it has participated in a $14.5 million private placement commitment to purchase common stock and warrants of GoAmerica, Inc. (Nasdaq: “GOAM” ). As part of the transaction, Little Bear also participated in a $1m bridge loan to GOAM, which closed Friday December 19, 2003.

Zachary Prensky, Managing Director of Little Bear, had originally overseen a $2m round of financing for GOAM in 1998. Mr. Prensky joined GOAM’s Board of Directors upon the closing of that financing in 1998 and stayed on until 2000.

“I am pleased to participate in a financing for a company that I had originally watched grow from a small 10-person firm into a publicly-traded leading provider of wireless services”, commented Mr. Prensky. “I was on the Board of Directors at the time the Wynd acquisition was being contemplated, and I am very pleased that GOAM has decided to focus on the core market of servicing customers who are deaf or hard of hearing.”

About GoAmerica

GoAmerica, Inc.’s aim is to improve the quality of life for people who are deaf or hard of hearing by being their premier provider of innovative communication services. These technology-based services are delivered through GoAmerica’s wholly owned subsidiaries, including Wynd Communications Corporation, the leading provider of wireless telecommunications services for people with hearing loss. Wynd Communications is a winner of the California Governor’s Award for Excellence in Universal Design and Technology and has been recognized by both the Clinton and Bush Administrations for its commitment to Americans with disabilities. For more information, visit or contact GoAmerica directly at TTY 800-549-2800, voice 805-781-6000.

About Little Bear

Little Bear Investments, located in the heart of Midtown Manhattan, is a merchant bank that focuses on investing in both public and private companies. Our broad range of investment experience includes: tender offers, private placements, PIPE’s, reverse mergers and bankruptcy auctions. Little Bear also offers financial, operational and strategic advisory services. Working with companies large and small, we bring the same disciplined approach to our clients as we do to businesses in which we have deployed our own capital.

If you have any questions regarding this press release, please contact Zachary Prensky at or at 212-946-2736.

” Concentration is my motto – first honesty, then industry, then concentration. ” Andrew Carnegie